CA Stock MarketDetailed Quotes

CSCI Cosciens Biopharma Inc

Watchlist
  • 4.210
  • +0.010+0.24%
15min DelayMarket Closed Nov 29 16:00 ET
13.15MMarket Cap-698P/E (TTM)

Cosciens Biopharma Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-4.15%1.87M
67.89%2.34M
-20.55%2.05M
-47.69%7.26M
-47.42%1.33M
-30.58%1.95M
-67.39%1.39M
-47.73%2.58M
2.93%13.88M
-9.41%2.53M
Operating revenue
-4.15%1.87M
67.89%2.34M
-20.55%2.05M
-47.69%7.26M
-47.42%1.33M
-30.58%1.95M
-67.39%1.39M
-47.73%2.58M
2.93%13.88M
-9.41%2.53M
Cost of revenue
-20.31%914K
155.13%1.52M
-17.57%1.15M
-25.74%4.28M
-28.39%1.14M
-0.25%1.15M
-54.20%595K
-29.04%1.4M
9.22%5.76M
115.47%1.59M
Gross profit
18.88%957K
2.76%819K
-24.05%901.72K
-63.26%2.98M
-79.60%192.2K
-51.56%805K
-73.16%797K
-60.10%1.19M
-1.12%8.12M
-54.24%942.03K
Operating expense
202.24%5.79M
139.35%4.57M
74.52%2.71M
89.30%7.7M
95.47%2.31M
120.28%1.92M
51.77%1.91M
71.86%1.56M
-27.64%4.07M
-8.53%1.18M
Selling and administrative expenses
102.16%2.99M
149.51%3.04M
46.21%1.65M
104.61%5.62M
137.76%1.79M
131.25%1.48M
45.76%1.22M
82.33%1.13M
6.61%2.75M
16.94%753.48K
-Selling and marketing expense
----
----
-44.20%3.37K
40.12%30.52K
----
----
----
42.47%6.05K
-41.07%21.78K
-32.71%6.64K
-General and administrative expense
102.16%2.99M
149.51%3.04M
46.69%1.65M
105.13%5.59M
135.78%1.76M
132.88%1.48M
47.02%1.22M
82.60%1.12M
7.31%2.73M
17.71%746.84K
Research and development costs
541.97%2.8M
121.42%1.53M
150.02%1.06M
57.38%2.07M
21.47%523.08K
89.74%436K
63.69%691K
49.04%424.14K
-56.67%1.32M
-33.77%430.61K
Operating profit
-335.10%-4.83M
-237.07%-3.76M
-392.70%-1.81M
-216.38%-4.72M
-776.78%-2.12M
-240.25%-1.11M
-165.13%-1.11M
-117.76%-367.79K
56.42%4.05M
-131.67%-242.06K
Net non-operating interest income (expenses)
4.35%-22K
8.33%-22K
4.84%-62.48K
382.15%190.78K
602.71%303.78K
-0.23%-23K
3.89%-24K
6.90%-65.65K
58.33%-67.62K
248.89%43.23K
Non-operating interest income
----
----
----
378.86%328.82K
----
----
----
----
--68.67K
----
Non-operating interest expense
-4.35%22K
-8.33%22K
-12.87%21.77K
0.86%96.59K
-165.32%-16.41K
0.23%23K
-3.89%24K
-5.56%24.99K
-19.62%95.76K
-13.40%25.13K
Total other finance cost
----
----
0.10%40.7K
2.31%41.46K
----
----
----
-7.70%40.66K
-6.06%40.52K
1,683.36%307.5838
Other net income (expenses)
-792.47%-1.01M
4,274.42%1.88M
-9.51%64.14K
-72.98%73.6K
-882.67%-186.4K
-26.37%146K
-71.12%43K
171.92%70.88K
71.70%272.4K
-89.69%23.82K
Gain on sale of security
--217K
--1.77M
231.11%24.6K
-111.51%-23.87K
----
----
----
78.06%-18.77K
448.62%207.37K
0.85%-48.31K
Special income (charges)
---1.46M
----
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
--1.46M
----
----
----
----
--0
----
----
----
----
Other non-operating income (expenses)
58.22%231K
153.49%109K
-55.90%39.53K
49.87%97.47K
-325.33%-162.53K
891.59%146K
507.52%43K
789.18%89.65K
-69.64%65.04K
-74.22%72.13K
Income before tax
-493.83%-5.87M
-73.15%-1.9M
-399.35%-1.81M
-204.57%-4.45M
-1,045.60%-2M
-202.12%-988K
-159.70%-1.1M
-119.07%-362.56K
64.56%4.26M
-118.11%-175.01K
Income tax
47.17%-112K
-101.70%-474K
-428.39%-411.54K
-188.65%-900.61K
-1,105.28%-375.61K
-192.74%-212K
-154.22%-235K
-117.34%-77.89K
2,019.77%1.02M
41.11%-31.16K
Earnings from equity interest net of tax
Net income
-641.62%-5.76M
-65.35%-1.42M
-391.40%-1.4M
-209.56%-3.55M
-1,032.67%-1.63M
-205.02%-776K
-161.39%-860K
-119.60%-284.67K
22.77%3.24M
-114.11%-143.85K
Net income continuous operations
-641.62%-5.76M
-65.35%-1.42M
-391.40%-1.4M
-209.56%-3.55M
-1,032.67%-1.63M
-205.02%-776K
-161.39%-860K
-119.60%-284.67K
22.77%3.24M
-114.11%-143.85K
Noncontrolling interests
Net income attributable to the company
-641.62%-5.76M
-65.35%-1.42M
-391.40%-1.4M
-209.56%-3.55M
-1,032.67%-1.63M
-205.02%-776K
-161.39%-860K
-119.60%-284.67K
22.77%3.24M
-114.11%-143.85K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-641.62%-5.76M
-65.35%-1.42M
-391.40%-1.4M
-209.56%-3.55M
-1,032.67%-1.63M
-205.02%-776K
-161.39%-860K
-119.60%-284.67K
22.77%3.24M
-114.11%-143.85K
Diluted earnings per share
-340.48%-1.85
-36.17%-0.64
-306.87%-0.6272
-202.31%-1.9165
-6,264.43%-0.8765
-235.55%-0.42
-171.46%-0.47
-122.71%-0.1541
40.92%1.8732
-95.73%0.0142
Basic earnings per share
-340.48%-1.85
-36.17%-0.64
-306.87%-0.6272
-202.31%-1.9165
-6,264.43%-0.8765
-235.55%-0.42
-171.46%-0.47
-122.71%-0.1541
40.92%1.8732
-95.73%0.0142
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -4.15%1.87M67.89%2.34M-20.55%2.05M-47.69%7.26M-47.42%1.33M-30.58%1.95M-67.39%1.39M-47.73%2.58M2.93%13.88M-9.41%2.53M
Operating revenue -4.15%1.87M67.89%2.34M-20.55%2.05M-47.69%7.26M-47.42%1.33M-30.58%1.95M-67.39%1.39M-47.73%2.58M2.93%13.88M-9.41%2.53M
Cost of revenue -20.31%914K155.13%1.52M-17.57%1.15M-25.74%4.28M-28.39%1.14M-0.25%1.15M-54.20%595K-29.04%1.4M9.22%5.76M115.47%1.59M
Gross profit 18.88%957K2.76%819K-24.05%901.72K-63.26%2.98M-79.60%192.2K-51.56%805K-73.16%797K-60.10%1.19M-1.12%8.12M-54.24%942.03K
Operating expense 202.24%5.79M139.35%4.57M74.52%2.71M89.30%7.7M95.47%2.31M120.28%1.92M51.77%1.91M71.86%1.56M-27.64%4.07M-8.53%1.18M
Selling and administrative expenses 102.16%2.99M149.51%3.04M46.21%1.65M104.61%5.62M137.76%1.79M131.25%1.48M45.76%1.22M82.33%1.13M6.61%2.75M16.94%753.48K
-Selling and marketing expense ---------44.20%3.37K40.12%30.52K------------42.47%6.05K-41.07%21.78K-32.71%6.64K
-General and administrative expense 102.16%2.99M149.51%3.04M46.69%1.65M105.13%5.59M135.78%1.76M132.88%1.48M47.02%1.22M82.60%1.12M7.31%2.73M17.71%746.84K
Research and development costs 541.97%2.8M121.42%1.53M150.02%1.06M57.38%2.07M21.47%523.08K89.74%436K63.69%691K49.04%424.14K-56.67%1.32M-33.77%430.61K
Operating profit -335.10%-4.83M-237.07%-3.76M-392.70%-1.81M-216.38%-4.72M-776.78%-2.12M-240.25%-1.11M-165.13%-1.11M-117.76%-367.79K56.42%4.05M-131.67%-242.06K
Net non-operating interest income (expenses) 4.35%-22K8.33%-22K4.84%-62.48K382.15%190.78K602.71%303.78K-0.23%-23K3.89%-24K6.90%-65.65K58.33%-67.62K248.89%43.23K
Non-operating interest income ------------378.86%328.82K------------------68.67K----
Non-operating interest expense -4.35%22K-8.33%22K-12.87%21.77K0.86%96.59K-165.32%-16.41K0.23%23K-3.89%24K-5.56%24.99K-19.62%95.76K-13.40%25.13K
Total other finance cost --------0.10%40.7K2.31%41.46K-------------7.70%40.66K-6.06%40.52K1,683.36%307.5838
Other net income (expenses) -792.47%-1.01M4,274.42%1.88M-9.51%64.14K-72.98%73.6K-882.67%-186.4K-26.37%146K-71.12%43K171.92%70.88K71.70%272.4K-89.69%23.82K
Gain on sale of security --217K--1.77M231.11%24.6K-111.51%-23.87K------------78.06%-18.77K448.62%207.37K0.85%-48.31K
Special income (charges) ---1.46M------------------0----------------
-Less:Impairment of capital assets --1.46M------------------0----------------
Other non-operating income (expenses) 58.22%231K153.49%109K-55.90%39.53K49.87%97.47K-325.33%-162.53K891.59%146K507.52%43K789.18%89.65K-69.64%65.04K-74.22%72.13K
Income before tax -493.83%-5.87M-73.15%-1.9M-399.35%-1.81M-204.57%-4.45M-1,045.60%-2M-202.12%-988K-159.70%-1.1M-119.07%-362.56K64.56%4.26M-118.11%-175.01K
Income tax 47.17%-112K-101.70%-474K-428.39%-411.54K-188.65%-900.61K-1,105.28%-375.61K-192.74%-212K-154.22%-235K-117.34%-77.89K2,019.77%1.02M41.11%-31.16K
Earnings from equity interest net of tax
Net income -641.62%-5.76M-65.35%-1.42M-391.40%-1.4M-209.56%-3.55M-1,032.67%-1.63M-205.02%-776K-161.39%-860K-119.60%-284.67K22.77%3.24M-114.11%-143.85K
Net income continuous operations -641.62%-5.76M-65.35%-1.42M-391.40%-1.4M-209.56%-3.55M-1,032.67%-1.63M-205.02%-776K-161.39%-860K-119.60%-284.67K22.77%3.24M-114.11%-143.85K
Noncontrolling interests
Net income attributable to the company -641.62%-5.76M-65.35%-1.42M-391.40%-1.4M-209.56%-3.55M-1,032.67%-1.63M-205.02%-776K-161.39%-860K-119.60%-284.67K22.77%3.24M-114.11%-143.85K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -641.62%-5.76M-65.35%-1.42M-391.40%-1.4M-209.56%-3.55M-1,032.67%-1.63M-205.02%-776K-161.39%-860K-119.60%-284.67K22.77%3.24M-114.11%-143.85K
Diluted earnings per share -340.48%-1.85-36.17%-0.64-306.87%-0.6272-202.31%-1.9165-6,264.43%-0.8765-235.55%-0.42-171.46%-0.47-122.71%-0.154140.92%1.8732-95.73%0.0142
Basic earnings per share -340.48%-1.85-36.17%-0.64-306.87%-0.6272-202.31%-1.9165-6,264.43%-0.8765-235.55%-0.42-171.46%-0.47-122.71%-0.154140.92%1.8732-95.73%0.0142
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data